Status:

UNKNOWN

Cilostazol Versus Aspirin for Primary Prevention of Atherosclerotic Events

Lead Sponsor:

Hanyang University

Collaborating Sponsors:

Ajou University School of Medicine

Kyunghee University Medical Center

Conditions:

Type 2 Diabetes Mellitus

Eligibility:

All Genders

40+ years

Phase:

PHASE4

Brief Summary

This multi-center, randomized controlled study aims to evaluate the efficacy of Cilostazol versus Aspirin for primary prevention of atherosclerotic events with Korean type 2 Diabetes Mellitus (DM) pat...

Eligibility Criteria

Inclusion

  • Type 2 diabetes mellitus with high risk of macrovascular complications; high risk is one or more as follows:
  • Hypertension (≧ 140/90 or anti-hypertensive therapy)
  • Hypercholesterolemia (LDL-C \> 130 mg/dL or anti-hyperlipidemic therapy)
  • TG \> 200 mg/dL
  • Non proliferative retinopathy or macular edema
  • Microalbuminuria or macroalbuminuria
  • Smoker
  • Patients on no anti PLT drug history
  • Patients who are agree with this research

Exclusion

  • Type 1 diabetes mellitus
  • Macrovascular complication history
  • Uncontrolled hypertension, unstable angina history
  • Congestive heart failure
  • Bleeding tendency
  • Chronic liver disease (ALT \> 100 or AST \> 100) or Chronic renal disease creatinine \> 3.0 mg/dl)
  • Anemia (hemoglobin \< 10 mg/dl) or thrombocytopenia (platelet count less than 100,000/mm3)
  • Pregnant or lactation women
  • Plan to be revascularized in 4 weeks
  • Plan to go to surgery or invasive intervention in 4 weeks
  • Plan to need to admission for acute cardiovascular disease in 4 weeks
  • Contraindication of this medication
  • Other anti-PLT drug therapy

Key Trial Info

Start Date :

April 1 2009

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

February 1 2014

Estimated Enrollment :

400 Patients enrolled

Trial Details

Trial ID

NCT00886574

Start Date

April 1 2009

End Date

February 1 2014

Last Update

June 4 2010

Active Locations (6)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (6 locations)

1

Inha University Hospital

Incheon, South Korea

2

Hallym University Hospital

Pyungcheon, South Korea

3

Hallym University Hospital

Seoul, South Korea

4

Korea University Guro Hospital

Seoul, South Korea